Cargando…
M6A-Related Bioinformatics Analysis Reveals a New Prognostic Risk Signature in Cutaneous Malignant Melanoma
Cutaneous malignant melanoma (CMM) is the most deadly skin cancer worldwide. Despite advances in the treatments of CMM, its incidence and mortality rates are still increasing. N6-methyladenosine (m6A) is the most common form of RNA modification and has attracted increasing interest in cancer initiat...
Autores principales: | Yu, Qingxiong, Zhu, Hainan, Wang, Huijing, Aimaier, Rehanguli, Chung, Manhon, Wang, Zhichao, Li, Qingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201746/ https://www.ncbi.nlm.nih.gov/pubmed/35722625 http://dx.doi.org/10.1155/2022/8114731 |
Ejemplares similares
-
Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response
por: Gu, Yihui, et al.
Publicado: (2022) -
Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors
por: Gu, Yihui, et al.
Publicado: (2022) -
Knockdown of NCOR2 Inhibits Cell Proliferation via BDNF/TrkB/ERK in NF1-Derived MPNSTs
por: Li, Yuehua, et al.
Publicado: (2022) -
Quality of Life in Chinese Patients With Large Congenital Melanocytic Nevi
por: Wang, Huijing, et al.
Publicado: (2022) -
Development of a Four-mRNA Expression-Based Prognostic Signature for Cutaneous Melanoma
por: Bai, Haiya, et al.
Publicado: (2021)